For citations:
Berstein L.M. Is cancer incidence modified by SGLT2 inhibitors? Diabetes mellitus. 2019;22(4):399-402. (In Russ.) https://doi.org/10.14341/DM10119
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
